| Name |
Cerebrolysin otopina za injekciju/infuziju |
| Marketing Authorisation Number |
HR-H-038860482 |
| Active Substance |
cerebrolizin, koncentrat |
| Composition |
1 ml otopine sadrži 215,2 mg niskomolekulske frakcije polipeptida ekstrahiranih iz mozga svinje (cerebrolysin koncentrat), što odgovara najmanje 5,8 mg dušika iz peptida (15%) i slobodnih aminokiselina (85%) |
| Pharmaceutical Form |
Otopina za injekciju / infuziju |
| Manufacturer |
Ever Neuro Pharma GmbH, Unterach am Attersee, Austrija |
| Marketing Authorisation Holder |
Ever Neuro Pharma GmbH, Oberburgau 3, Unterach am Attersee, Austrija |
| Marketing Authorisation Date |
28.02.2020 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/631 |
| Registration Number |
381-12-01/38-20-09 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
N07X |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
